baber/WOPTO huggingface dataset:
Patent JP-H10504917-A (JP)
Title: ヘッドマウントディスプレイ用衝突警告システム
IPC: G02B27/22
Filed: 1996-04-18
Abstract: (57)【要約】
例えば仮想現実システムに対するインタフェースとしてユーザが装着し、物理的環境内における近接する対象物に関して警告を与えるようなヘッドマウントディスプレイ（１０）に関する衝突警告システムが開示されている。動き検出器（３０、３２）が、ヘッドマウントディスプレイの位置的な変化を検出する。これら変化は、表示される映像の視野の変化に対応し、比較段（３８、４０）が、その移動によりユーザが“禁止”領域に入るかどうかを決定する。もしそうであるならば、映像的及び／または可聴警告が、ヘッドマウントディスプレイ（１０）を介してユーザに提供される。一実施例においては、ヘッドマウントディスプレイのディスプレイスクリーン（１８）が、液晶ディスプレイシャッタ（２０）を有する。このシャッタ（２０）は、衝突が差し迫った場合に、ユーザに危険の警告を与えるだけではなくヘッドマウントディスプレイを取り外すまたは調整する必要なくその危険を分からせるように、透過状態に切替えられる。
Patent JP-2001514812-A (JP)
Title: バイナリ連結キャパシタを備える遅延ロックループ
IPC: H03K5/13
Filed: 1998-03-05
Abstract: (57)【要約】
バイナリ結合されたキャパシタをキャパシタバンク内に援用した遅延ロックループが、遅延ラインに沿って可変キャパシタンスを発生する。可変キャパシタンスは、可変遅延ラインの遅延を可変させる。入力クロック信号に応答して、可変遅延ラインが、レース検出回路で入力信号と比較される遅延出力信号を発する。遅延クロック信号が、入力クロック信号に先行する場合に、レース検出回路は、バイナリ結合されたキャパシタを制御するカウンタを増大させる。増大したカウンタは、追加のキャパシタンスを可変遅延ラインに結合することによって、キャパシタンスを増大させ、遅延クロック信号の遅延を伝播する。遅延クロック信号が元のクロック信号に遅延する場合、レース検出回路はカウンタを減少させてキャパシタンスを減少させ、これによって、可変遅延ラインの遅延を減少させる。レース検出回路は、遅延クロック信号および可変クロック信号が実質的に同期的であるときを検出し、これに応答してカウンタの増大または減少をディスエーブルするアービトレーション回路を含む。
Patent JP-2001520860-A (JP)
IPC: H02K33/16
Filed: 1999-02-03
Abstract: A linear uniphase polarized electromagnetic actuator. The actuator includes a coiled stator and one part which is movable in the direction OX with the useful travel of Xc. The movable part is moved according to the current traveling in the coil and the direction of travel depends on the direction of the current. The movable part includes a yoke of soft magnetic material having at least one magnet coupled with the yoke. The magnet is partially set inside a cavity of the mobile yoke on the side of the stator poles at a depth e such that 0.1 L<e<0.9 L, where E is the distance measured perpendicularly to OX between the stator poles and the cavity end pole.
Patent JP-2001517081-A (JP)
Title: 機能性タンパク質の産生：剪断応力と重力との釣合い
IPC: C12N5/00
Filed: 1998-04-07
Abstract: (57)【要約】
本発明は、回転壁容器を用いた剪断応力に反応する三次元共培養プロセスにおいて腎細胞により、ホルモンを含有する機能性タンパク質を産生する方法を提供する。腎細胞の天然混合物は、ビタミンＤの活性形態：１，２５−ジＯＨビタミンＤ３を産生するのに使用できる酵素１−ａ−ヒドロキシラーゼを発現する。腎皮質細胞の共培養液および繊維芽細胞培養液は、エリスロポイエチンの遺伝子を発現し、エリスロポイエチンを培養上澄み中に分泌する。トキシンレセプタのメガリンおよびキュビュリン（ｇｐ２８０）のような他の剪断応力反応遺伝子も、剪断応力により変調される。回転壁容器を用いた応力に反応する三次元共培養プロセスにおいて産生された機能性タンパク質により、必要とする個人を治療する方法も提供される。
Patent JP-2001518853-A (JP)
Title: 製紙用スラッジ改質方法及びこれから製造された製品
IPC: D21H11/14
Filed: 1998-03-27
Abstract: (57)【要約】
製紙スラッジは、ポリアクリルアミドのような１か、２以上の分散剤を添加することによって、モデルクレー状の密度に改質される。改質された製紙スラッジ（1：33）は、シート（4；40）のような有効な複数の製品または押し出された製品（43）に形成できる。
Patent JP-2000511205-A (JP)
Title: キラルなペプチド核酸とその製造方法
IPC: C07C271/22
Filed: 1998-04-08
Abstract: (57)【要約】
骨格にキラリティーを有するペプチド核酸モノマー、その合成法及びそれから製造されるペプチド核酸オリゴマーが提供される。
Patent JP-2001524173-A (JP)
Title: ポリビニルアルコール煙草用フィルターおよびその様なフィルターを使用する製品、およびそれらを製造するための方法および装置
IPC: D04H3/16
Filed: 1998-03-24
Abstract: (57)【要約】
特に紙巻き煙草(１６)、等に関連する煙草用フィルタープラグとして使用する多孔質素子（２０）で、マトリックスが複数の生物分解性ポリビニルアルコール繊維を含んでなり、繊維がそれらの接触点で結合し、煙を通すための曲がりくねった隙間通路を限定する。ポリビニルアルコールの吸湿性のために、その様な製品の商業的製造では、ポリビニルアルコール繊維出発材料の含水量を注意深く調整する必要があり、通常は、繊維を残留含水量７重量％以下に予備乾燥し、低含水量材料を過熱蒸気で処理し、約２．５〜５重量％の水分を加え、最終含水量を約２．５〜１０重量％にする。蒸気は繊維表面に接着性を付与し、結合可能にし、また集めた繊維を潤滑して加工性を改善する。
Patent JP-2001525089-A (JP)
IPC: G08B13/24
Filed: 1998-04-30
Abstract: The present invention is directed to a method and a device for the production of security elements for electronic article surveillance, the security elements being comprised of at least two layers, as well as to a web material manufactured by means of the method the present invention proposes a simple, economical method, a corresponding device for the production of web material, as well as to a web material manufactured by the method for the purpose of electronic article surveillance. With regard to the method of the present invention, it is accomplished in that sections of a predetermined length cut from a second material web are conveyed in a direction transverse to the running direction of a first continuous material web and are applied to the first material web.
Patent NZ-193127-A (NZ)
Title: Penicillins medicinal preparations biocides
Inventor: WETZEL B
IPC: C07D499/70
Filed: 1980-03-14
Abstract: Compounds of the formula   <IMAGE>  and  <IMAGE>  wherein A is phenyl, p-hydroxy-phenyl, 2-thienyl, 3-thienyl or 3,4-disubstituted phenyl, where the substituents, which may be identical to or different from each other, are each chlorine, hydroxyl or methoxy; R is -NH-Z-X; Z is straight or branched alkylene of 1 to 6 carbon atoms or cycloalkylene of 3 to 6 carbon atoms; X is cyano, hydroxyl, mercapto, aminocarbonyl, aminosulfonyl,   <IMAGE>  <IMAGE> +TR OR1, OCOR1, SR1, SOR1 or SO2R1;   R1 is straight or branched alkyl of 1 to 4 carbon atoms or phenyl;  R2 is hydrogen or alkyl of 1 to 4 carbon atoms; and  R1 and R2, together with an adjacent nitrogen atom to which they are attached, form a 3- to 6-membered heterocyclic ring; and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases.
Patent NZ-236417-A (NZ)
Title: Amino pyrimidine derivative, preparation, intermediates, and pharmaceutical compositions thereof
Inventor: MILLS STUART DENNETT
IPC: C07D239/48
Filed: 1990-12-10
Abstract: This invention concerns compounds of the formula I: <CHEM> wherein R<1> is (1-10C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, phenyl or phenyl(1-4C)alkyl, the phenyl moiety of the latter two optionally bearing one or more substituents; R<2> is hydrogen, (1-4C)alkyl, amino or (1-4C)alkylamino; R<6> is (1-4C)alkyl, amino or (1-4C)alkylamino; Q is a group of formula II, in which case R<3> and R<4> are independently hydrogen, (1-4C)alkyl, phenyl or benzyl the phenyl moiety of the latter two optionally bearing one or two substituents; R<5> is hydrogen, (1-4C)alkyl or (2-4C)alkenyl; A and B are independently ethylene or trimethylene; Z is a direct bond between A and B, or an oxy, thio, carbonyl, methylene, ethylenedioxymethylene, ethylidene, or isopropylidene link, or Z is a group of the formula =N.M in which M is hydrogen, (1-6C)alkyl, phenyl or benzyl, the phenyl moiety of the latter two optionally bearing one or two substituents; or Q represents a saturated 9- or 10-membered bicyclic amino group, which is unsubstituted or is substituted by one or two substituents; and Y is a physiologically acceptable anion. The invention also includes certain closely related anhydro-base derivatives which, like the compounds of formula I, possess beneficial effects on the cardiovascular system (and in particular beneficial effects modulated via the sino-atrial node). Also included are pharmacuetical compositions containing compounds of formula I (or a related anhydro-base) as active ingredient, and processes for the manufacture of the various novel compounds.
Patent NZ-239408-A (NZ)
Title: Benzimidazole and imidazopyridine derivatives and pharmaceutical
Inventor: WHITTAKER MARK
IPC: C07D235/26
Filed: 1991-08-15
Abstract: Compounds of general formula I;  (* CHEMICAL STRUCTURE *) I wherein: A1 is =N-, =CH- or =CR1-; A2 is =N-, =CH- or =CR2-; provided that, when one of A1 and A2 is a nitrogen atom, the other of A1 and A2 is other than a nitrogen atom; wherein the rest of the variables are defined in the specification; and their pharmaceutically and veterinarily acceptable acid addition salts and hydrates are antagonists of platelet activating factor (PAF) and as such are useful in the treatment or amelioration of various diseases or disorders mediated by PAF.
Patent NZ-240271-A (NZ)
Title: Hexahydro-(4-(4-(2-methoxyphenyl)-piperazine-1-yl)-2-phenylbutyryl)azepine; pharmaceutical compositions and preparatory processes
Inventor: CLIFFE IAN ANTHONY
IPC: A61P25/20
Filed: 1991-10-17
Abstract: 2,3,4,5,6,7-Hexahydro-1- &lsqbstr& 4-[1-[4-(2-methoxyphenyl)-piperazinyl]]-2-phenylbutyryl &rsqbstr& -1H-azepin e and the pharmaceutically acceptable acid addition salts thereof are 5-HT1A binding agents useful, for example, as anxiolytics.
Patent NZ-246567-A (NZ)
Title: Variant polypeptides of a human kunitz type protease inhibitor domain and pharmaceutical compositions thereof
Inventor: BJORN SOREN ERIK
IPC: A61K38/00
Filed: 1993-01-07
Abstract: A variant of the C-terminal Kunitz-type protease inhibitor domain of the  alpha 3 chain of human type VI collagen, the variant comprising the following amino acid sequence X1 X16 Asp Ile Cys Lys Leu Pro Lys Asp X2 Gly X3 Cys X4 X5 X6 X7 X8 X9 Trp Tyr Tyr Asp Pro Asn Thr Lys Ser Cys Ala Arg Phe X10 Tyr Gly Gly Cys X11 X12 X13 Glu Asn Lys Phe X14 Ser Gln Lys Glu Cys Glu Lys Val Cys Ala Pro X15 (SEQ ID NO. 1) wherein X1, X15, and X16 represents a naturally occurring amino acid residues except Cys and X2-X14 each independently respresents a naturally occurring amino acid residue, with the proviso that at least one of the amino acid residues X1-X16 is different from the corresponding amino acid residue of the native sequence. Alternatively, the N-terminal Asp may be preceded by H or 3-5 amino acid residues and the C-terminal Pro may be followed by OH or 3-5 amino acid residues.
Patent NZ-249494-A (NZ)
Title: Itraconazole and saperconazole stereoisomers; pharmaceutical compositions
Inventor: HEERES JAN
IPC: C07D405/14
Filed: 1993-03-10
Abstract: Anti-infective compositions for the treatment of a human in need of therapy for a systemic or topical fungal infection which comprise a pharmaceutically acceptable carrier and a therapeutically effective amount of (2R,4S) itraconazole or a pharmaceutically acceptable salt thereof, substantially free of its (2S,4R) stereoisomer.
Patent NZ-254689-A (NZ)
Title: Article recycling: apparatus for controlled storage of used articles with controlled dispensing of new articles
Inventor: JENKINS ALAN ERNEST
IPC: B65F1/00
Filed: 1993-08-13
Abstract: PCT No. PCT/AU93/00416 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Aug. 13, 1993 PCT Pub. No. WO94/04446 PCT Pub. Date Mar. 3, 1994The present invention relates to a method and apparatus adapted to promote the recycling of complex articles, such as, in particular, printer cartridges, toner cartridges and other complex office items. The invention provides an apparatus having storage space arranged to store a number of such complex articles for recycling. Access to the storage space is controlled by a data processor which interacts with a user by way of a visual display unit and control panel. If the user wishes to store an item, he indicates this by way of the control panel and the apparatus is then operable to open a receptacle to receive the used item. When the used item is placed in the receptacle, in preferred embodiments means are provided to determine that the used item is an article of an appropriate type to be stored. These means preferably employ shape recognition. The article will be rejected if it is not of the correct type and accepted and retained in a storage space if it is of the correct type. The preferred apparatus is also arranged to dispense items on request by the user. A preferred feature is that the apparatus will not dispense a new or recycled item if a predetermined ratio of new items dispensed to used items stored by that user would be exceeded. This encourages recycling.
Patent NZ-276285-A (NZ)
Title: 4-silyl phenols used in lowering serum cholesterol levels
Inventor: MAO SIMON JEN TAN
IPC: A61P17/00
Filed: 1994-11-03
Abstract: The compounds - 2,6-di-t-butyl-4-[(4-chlorophenyldimethylsilyl)methyloxy]phenol; 2,6-di-t-butyl-4-[dimethyl-4-fluorophenylsilyl)methyloxy]phenol; 2,6-di-t-butyl-4-[dimethylphenylsilyl)methyloxy]phenol; 2,6-dimethyl-4-[(dimethylphenylsilyl)methyloxy]phenol; 2-t-butyl-6-methyl-4-[(dimethylphenylsilyl)methylthio]phenol; 2,6-di-t-butyl-4-[(dimethyl-2,5-dimethoxyphenylsilyl)methyloxy]phenol; 2,6-di-t-butyl-4-[(dimethyl-2,3-dimethoxyphenylsilyl)methyloxy]phenol; 2,6-di-t-butyl-4-[(dimethyl-4-t-butylphenylsilyl)methyloxy]phenol and 2,6-di-t-butyl-4-[(benzyldimethylsilyl)methyloxy]phenol are useful for lowering plasma cholesterol levels. A 2,6-di-alkyl-4-silyl-phenol compound of formula (I) is used in the manufacture of a medicament for lowering the plasma cholesterol level in a patient wherein in formula (I): R1, R2, R3 and R4 are independently alkyl; Z is a thio, oxy or methylene; A is alkylene; R5 is alkyl or -(CH2)n-(Ar); n is 0, 1, 2 or 3 and Ar is optionally substituted phenyl or naphthyl.
Patent NZ-285941-A (NZ)
Title: Papillomavirus vaccine and recombinant virus-like particles comprising human papillomavirus protein
Inventor: JANSEN KATHRIN U
IPC: A61K39/00
Filed: 1995-06-02
Abstract: Recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins and purified virus-like particles comprised of the recombinant proteins are provided.
Patent NZ-330973-A (NZ)
Title: Azolobenzazepine derivatives as neurologically active agents
Inventor: BRUSH KELLY ANNE
IPC: A61P9/00
Filed: 1997-03-04
Abstract: The application relates to azolobenzazepine derivatives of formula (I), wherein: X is O or S; R1, R2, R3 and R4 are independently hydrogen, perfluorolower-alkyl, halogen, nitro or cyano; and C together with the carbon atoms to which it is attached forms a 5-membered aromatic heterocycle. Also included are pharmaceutical compositions containing these compounds.
Patent NZ-333095-A (NZ)
Title: Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
Inventor: LANG HANS JOCHEN
IPC: A61K31/365
Filed: 1997-05-20
Abstract: Use of Na+/H+ exchange inhibitors benzoylguanidines of the formula 1 where: R(1) or R(2) is R(6)-S(O)n- or R(7)R(8)N-02S-; and the other substituent R(1) or R(2) in each case are H, F, Cl, Br, (C1-C4)-alkyl, (C1-C4)-alkoxy or phenoxy, is unsubstituted or substituted by 1 - 3 substituents selected from F, Cl, methyl and methoxy; or the other substituent R(1) or R(2) is: R(6)-S(O)n or R(7)R(8)N-; n is 0, 1 or 2; R(6) is (C1-C6)-alkyl, (C5-C7)-cycloalkyl, cyclopentylmethyl, cyclohexylmethyl or phenyl, which is unsubstituted or substituted by 1 - 3 substituents selected from F, Cl, methyl and methoxy R(7) and R(8) are H or (C1-C6)-alkyl; or R(7) is phenyl-(CH2)m; m is 1-4; or R(7) is phenyl, which is unsubstituted or substituted by 1 - 2 substituents selected from F, Cl, methyl and methoxy or R(7) and R(8) together are straight chain or branched (C4-C7) chain, where the chain can additionally be interrupted by O, S or NR9; R(9) is H, Methyl; or R(7) and R(8) together with the nitrogen atom to which they are bonded are a dihydroindole tetrahydroquinoline or tetrahydroisoquinoline system; R(3), R(4} and R(5) independently are H or C1-2 alkyl or R4 and R5 are C4-7 alkylene chain
Patent NZ-334932-A (NZ)
Title: Apparatus for controlling gas temperature in compressors
Inventor: CONEY MICHAEL WILLOUHGBY ESSEX
IPC: F04B39/06
Filed: 1997-10-14
Abstract: An apparatus is provided for controlling gas temperature during compression or expansion.  The apparatus comprises a chamber for containing gas, a piston 43 for changing the volume of gas in the chamber, a plurality of atomisers 45 for spraying liquid into the chamber and means for delivering liquid to the atomisers.  Each atomiser 45 comprises a spray aperture and means defining a flow path for imparting rotary motion to the flow of liquid about the axis of the aperture so that on leaving the aperture the liquid divides into a conical spray.  The spray apertures are positioned adjacent one another and the axes of adjacent spray apertures are oriented such that their respective sprays intersect at a position proximate at least one of the respective adjacent spray apertures.
Patent NZ-335240-A (NZ)
Title: A method of supplying liquid from a floating container
Inventor: PRATT SIMON MICHAEL
IPC: E03B11/00
Filed: 1997-09-26
Abstract: A method of supplying liquid comprises the steps of: 1)	provide at a first location, a cistern (4) on land for liquid; 2)	provide at a second location, a floating flexible container (1) of liquid; and 3)	incrementally convey liquid from the container to the cistern according to a demand determined according to the use of liquid in the cistern. In the example shown in the accompanying figure, the liquid is pumped from the flexible container to a first cistern (3) using a pumping means provided on a moveable buoy (2).
Patent NZ-335332-A (NZ)
Title: Process for the preparation of 2-hydroxy 4-methylthiobutyric acid using a nitrilase
Inventor: FAVRE-BULLE OLIVIER
IPC: C12N15/09
Filed: 1997-10-24
Abstract: A method for preparing 2-hydroxy 4-methylthiobutyric acid and/or the ammonium salt of 2-hydroxy 4-methylthiobutyric acid by enzymatic hydrolysis of 2-hydroxy 4-methythiobutyronitrile characterised in that: a) a biological material having nitrilase activity is prepared, b) the biological material is immobilised, c) 2-hydroxy 4-methylthio butyronitrile is brought in the presence of the immobilised biological material, for obtaining the ammonium salt of 2-hydroxy 4-methylthio butyric acid, d) optionally, the salt obtained in step c) is transformed into the corresponding acid, and e) the product resulting from step c) or d) is concentrated.
Patent NZ-336043-A (NZ)
Title: Use of COMT inhibitors for preventing diabetic vascular dysfunctions or neuropathy
Inventor: APERIA ANITA CHATARINA
IPC: A61K45/00
Filed: 1997-12-19
Abstract: Catechol-O-methyl transferase (COMT) inhibitors or their pharmaceutically acceptable salt such as nitecapone are used in the manufacture of a medicament for preventing diabetic vascular dysfunctions or neuropathy.
Patent NZ-336578-A (NZ)
Title: Flexible pre-stressed concrete vinyard post having an unbonded steel strap within
Inventor: ALLAN COLIN JOHN
IPC: E04H17/20
Filed: 1999-07-06
Abstract: concrete post reinforced along its entire length with a band of prestressed steel 2 extending parallel to a longitudinal axis of the concrete post is claimed.  The concrete post has two ends and an intermediate portion.  The concrete is free to move relative to the steel band at the intermediate portion.
Patent NZ-501459-A (NZ)
Title: Pillar type telephone junction box, collar fitted between cover and base
Inventor: O'TOOLE LARRY VINCENT
IPC: H02G15/10
Filed: 1999-12-02
Abstract: A telephone connection junction box or pillar 10 consists of a base 14 which is fixed to the ground, a collar 12 and a cover 16.  The collar fits over base 14, and has apertures for cables and wires to pass though it.  The collar has O-ring seals to provide a weather-tight seal between the base and collar, and between the collar and cover.  Columns of connection modules 26 are mounted around the inner surface of the cover.  The number of modules in each column can be altered by using a cover with a different height.
Patent NZ-502088-A (NZ)
Title: Characterising nucleic acids using mass spectroscopy
Inventor: SCHMIDT GUNTER
IPC: C12Q1/68
Filed: 1998-07-13
Abstract: A method for characterising DNA comprising: (i) providing a population of DNA fragments, each fragment having cleavably attached thereto a mass label for identifying a feature of that fragment; (ii) separating the fragments on the basis of their length; (iii) cleaving each fragment in a mass spectrometer to release its mass label; and (iv) determining each mass label by mass spectroscopy to relate the feature of each fragment to the length of the fragment.
Patent NZ-503232-A (NZ)
Title: Melt processable starch compositions comprising amylopectin and a high polymer (such as polyacrylamide)
Inventor: MACKEY LARRY NEIL
IPC: A23L27/50
Filed: 2000-03-06
Abstract: A flexible absorbent structure is produced comprising starch fibers. Naturally occurring starch in the presence of water, plasticisers and other additives are melt extruded and spun bonded to form low density, absorbent, flexible structures. The structures exhibit properties matching those of consumer paper products such as paper towels, toilet tissue, napkins , wet wipes, and the like. The melt processable composition comprising (a) from 20-99.99 wt% of a starch having a weight molecular average of between 1,000 to 2,000,000 and (b) from 0.001 to 10wt% of a high polymer, wherein the high polymer is substantially compatible with the starch, and the weight-average molecular weight of the high polymer is at least 500,000.
Patent NZ-504487-A (NZ)
Title: Combination of alpha-adrenergic antagonists and cGMP elevators for the treatment of impotence
Inventor: WYLLIE MICHAEL GRANT
IPC: A61K31/535
Filed: 1998-10-29
Abstract: Described is the oral or topical treatment of erectile dysfunction with a combination of (1) a compound selected from alpha -adrenergic receptor antagonists, and (2) a compound selected from agents which elevate cGMP levels.  Sildenafil or a pharmaceutically acceptable salt thereof is preferred as the cGMP PDEv elevator.  Also included are compositions and kits comprising these impotence-treating compounds.
Patent NZ-506747-A (NZ)
Title: Screening for blood coagulation defects using metal ions
Inventor: ROSEN BERT STEFFEN
IPC: G01N33/86
Filed: 1999-03-11
Abstract: An  in vitro photometric method for screening for  the determination  of  free  Protein  S  activity  or  for   the determination  of Protein C activity or for defects  in  the Protein  C anticoagulant pathway of blood coagulation  in  a blood sample of a human, comprising a)    incubating  the  blood sample  comprising  coagulation factors   with  incubation  components  including  exogenous activated  Protein C together with an activator  of  Protein C,  a suitable coagulation activator, an exogenous synthetic substrate   for  either  Factor  Xa  or  thrombin   with   a photometrically  measurable leaving group, calcium  ions  to trigger coagulation, further metal ions such as Mg2+,  Mn2+, Zn2+, Cu2+, Ni2+, Sr2+, Cu+ b)    determining  the  conversion  rate  of  the  exogenous substrate c)     comparing   the  conversion  rate  with   a   control conversion rate.
Patent NZ-511159-A (NZ)
Title: Apparatus for cooling a box with heat generating elements received therein and a method for cooling same
Inventor: SASAKI CHIYOSHI
IPC: H05K7/20
Filed: 2000-08-15
Abstract: A method for cooling a box with a heat generating element (8) inside by; 1) arranging in the box an air intake port (9) and a discharge port and installing a heat dissipating fin (6) in the box; 2) disposing a part or a whole of said heat dissipating fin close to the air intake port within the box; and 3) causing the air taken in from the intake port to pass through the heat dissipating fin to dissipate heat generated by the element, and then discharging air with a temperature raised by passing through the heat dissipating fin from the discharge port to the outside of the box.
Patent NZ-512987-A (NZ)
Title: Facing system for a flat panel radiator
IPC: H04R7/04
Filed: 2001-07-17
Abstract: A flat panel radiator assembly comprising: (i) a frame, (ii) a radiating panel resting within the frame, the radiating panel having a backing side and a facing side, (iii) at least one acoustic transducer operatively connected to the backing side of the radiating panel, and (iv) an acoustically transparent facing concealing the facing side of the radiating panel; the acoustic facing being chosen to be visually indistinguishable from the surrounding ceiling panel facing side. Also described is a ceiling system that comprises a plurality of ceiling tiles having an exposed surface and the flat panel sound radiator assembly defined above.
Patent NZ-518589-A (NZ)
Title: Substituted pyridines and pyridazines with angiogenesis inhibiting activity
Inventor: DUMAS JACQUES P
IPC: A61P9/10
Filed: 2000-09-26
Abstract: Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) are disclosed, wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R1 and R2 may be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and their suitability for use in treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermeability processes using these materials are also disclosed.